Publication|Articles|July 8, 2024
Supplements and Featured Publications
- Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Breaking the Cycle of Dry Eye Disease: Evidence for Cyclosporine Ophthalmic Solution, 0.09%
Advertisement
This clinical brief provides a background on DED and reviews DED treatment and challenges associated with prescription eye drops.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
GLP-1 Use Remains Rare Among Eligible Patients With Multiple Sclerosis
3
Sarcoma Gene Signature May Predict Who Benefits From Pazopanib
4
Lifestyle Factors Offer Actionable Targets in MASLD Management: Zobair M. Younossi, MD
5